Skip to main content
German

Investors

About Nevro

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. Senza systems are the only SCS systems that delivers Nevro's proprietary HF10® therapy.

Our Commitment to ESG

We recognize the growing importance of ESG to our stakeholders: customers, patients, shareholders, employees, suppliers and communities. We are committed to operating our business as a responsible corporate citizen and strengthening the trust our stakeholders place in us.

– D. Keith Grossman, Chairman, CEO and President

View ESG Report
Esg
Annual Report

Annual Reports

Access our annual report providing the financial profile and achievements of the prior year
View Report
Leadership

Leadership

Meet the group of experienced executives committed to our mission.
Meet the Team
Outcomes

Outcomes

Access the clinical evidence portfolio supporting our technology
View Research

Event RSS Feed (opens in new window) Latest Events and Presentations

All events and presentations

Press Release RSS Feed (opens in new window) News Releases

More News

Contact Nevro

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Nevro Corp., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Nevro Corp. to send you the requested Investor Email Alert updates.

* Required
*
*

Quick links